GNW Genworth Financial, Inc.
Genworth Financial, Inc., together with its subsidiaries, provides mortgage and long-term care insurance products in the United States. It operates through two segments: Enact and Closed Block. The company offers primary mortgage, and mortgage insurance products, and contract underwriting services. It also provides long-term care insurance products that are intended to protect against the significant and escalating costs of long-term care services provided in the insured's home, assisted living, and nursing facilities. In addition, the company offers protection and retirement income products, that includes traditional and non-traditional life insurance, such as term, universal and term universal life insurance, corporate-owned life insurance, and funding agreements; fixed annuities; and variable annuities. It distributes its products through sales force, sales representatives, and digital marketing programs. Genworth Financial, Inc. was founded in 1871 and is headquartered in Glen Allen, Virginia.…
Industry Peers
Insurance - LifeKey Statistics
About Genworth Financial (NYSE: GNW)
›
Genworth Financial (NYSE: GNW) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Insurance - Life industry, part of the Financial Services sector, and reports about 3,100 employees.
The shares were at 7.690 USD on 19 November 2026, down 9.8% over 52 weeks. Its 52-week range is 7.610 USD to 10.69 USD: the price is 28.1% below the high and 1.1% above the low.
At a market capitalisation of 2.82B USD, it trades at 76.9 times trailing earnings and 6.7 times forward earnings. The median trailing P/E of its 19 largest Insurance - Life peers is 11.4, a premium of 574% for GNW.
Genworth Financial reports return on equity of 2.5%, an operating margin of 4.5% and revenue down 7.1% year over year.
Its debt exceeds its cash by 258.00M USD, a debt-to-equity ratio of 0.17. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. One analyst covers the stock, with an average rating of Hold; their mean price target of 10.50 USD is 36.5% above the current price. The next earnings report is expected on 1 March 2027.